Skip to main content

Advertisement

Log in

Impact of sentinel lymph node biopsy in patients with Merkel cell carcinoma: results of a prospective study and review of the literature

  • Original article
  • Published:
European Journal of Nuclear Medicine and Molecular Imaging Aims and scope Submit manuscript

Abstract

Purpose

Merkel cell carcinoma (MCC) is the most aggressive of the cutaneous malignancies, showing a propensity to spread to regional lymph nodes (LNs). The aim of this prospective study was to examine the feasibility and clinical impact of sentinel lymph node biopsy (SLNB) in this cutaneous malignancy.

Methods

The study population comprised 23 patients with stage I MCC (median age 70 years, range 50–85 years). Lymphoscintigraphic mapping with 99 mTc-nanocolloid was performed in all patients. Sentinel lymph nodes (SLNs) were identified, excised and analysed in serial sections by conventional histopathology and cytokeratin-20 immunohistochemistry.

Results

Metastatic disease was determined in the SLNs of 11 patients (47.8%). Elective lymph node dissection (ELND) was performed in eight of these 11 patients, four of whom had additional positive LNs. During follow-up (median 36.1 months, range 3–79 months), seven of the 23 patients (30%) relapsed: four had a local recurrence and three, in-transit metastases. Recurrence developed in two SLN-negative patients with local LN metastases and in one SLN-positive patient with distant metastases. This patient died, representing the only tumour-related death in our sample. Median survival was 49.1 and 35.5 months for SLN-negative and SLN-positive patients, respectively. This difference was not statistically significant (p=0.3452).

Conclusion

SLNB allows for exact nodal staging in patients with MCC. Whether additional ELND is of further benefit remains unclear.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Hitchcock CL, Bland KI, Laney RG 3rd, Franzini D, Harris B, Copeland EM 3rd. Neuroendocrine (Merkel cell) carcinoma of the skin. Its natural history, diagnosis, and treatment. Ann Surg 1988;207:201–7

    Article  PubMed  CAS  Google Scholar 

  2. Shaw JH, Rumball E. Merkel cell tumour: clinical behaviour and treatment. Br J Surg 1991;78:138–42

    Article  PubMed  CAS  Google Scholar 

  3. Yiengpruksawan A, Coit DG, Thaler HT, Urmacher C, Knapper WK. Merkel cell carcinoma. Prognosis and management. Arch Surg 1991;126:1514–9

    PubMed  CAS  Google Scholar 

  4. Raaf JH, Urmacher C, Knapper WK, Shiu MH, Cheng EW. Trabecular (Merkel cell) carcinoma of the skin. Treatment of primary, recurrent, and metastatic disease. Cancer 1986;57:178–82

    Article  PubMed  CAS  Google Scholar 

  5. Miller RW, Rabkin CS. Merkel cell carcinoma and melanoma: etiological similarities and differences. Cancer Epidemiol Biomarkers Prev 1999; 8:153–8. Erratum in: Cancer Epidemiol Biomarkers Prev 1999 8:485

    PubMed  CAS  Google Scholar 

  6. Poulsen M. Merkel-cell carcinoma of the skin. Lancet Oncol 2004;5:593–9

    Article  PubMed  Google Scholar 

  7. Goessling W, McKee PH, Mayer RJ. Merkel cell carcinoma. J Clin Oncol 2002;20:588–98

    Article  PubMed  Google Scholar 

  8. Victor NS, Morton B, Smith JW. Merkel cell cancer: is prophylactic lymph node dissection indicated? Am Surg 1996;62:879–82

    PubMed  CAS  Google Scholar 

  9. Voog E, Biron P, Martin JP, Blay JY. Chemotherapy for patients with locally advanced or metastatic Merkel cell carcinoma. Cancer 1999;85:2589–95

    Article  PubMed  CAS  Google Scholar 

  10. Kokoska ER, Kokoska MS, Collins BT, Stapleton DR, Wade TP. Early aggressive treatment for Merkel cell carcinoma improves outcome. Am J Surg 1997;174:688–93

    Article  PubMed  CAS  Google Scholar 

  11. Krenning EP, Kwekkeboom DJ, Bakker WH, Breeman WA, Kooij PP, Oei HY, et al. Somatostatin receptor scintigraphy with [111In-DTPA-D-Phe1]- and [123I-Tyr3]octreotide: the Rotterdam experience with more than 1000 patients. Eur J Nucl Med 1993;20:716–31

    Article  PubMed  CAS  Google Scholar 

  12. Seregni E, Chiti A, Bombardieri E. Radionuclide imaging of neuroendocrine tumours: biological basis and diagnostic results. Eur J Nucl Med 1998;25:639–58

    Article  PubMed  CAS  Google Scholar 

  13. Kwekkeboom DJ, Krenning EP, de Jong M. Peptide receptor imaging and therapy. J Nucl Med 2000;41:1704–13

    PubMed  CAS  Google Scholar 

  14. Oberg K. State of the art and future prospects in the management of neuroendocrine tumors. Q J Nucl Med 2000;44:3–12

    PubMed  CAS  Google Scholar 

  15. Boerman OC, Oyen WJG, Corstens FHM. Radio-labeled receptor-binding peptides: a new class of radiopharmaceuticals. Semin Nucl Med 2000;30:195–208

    Article  PubMed  CAS  Google Scholar 

  16. Lampreave JL, Benard F, Alavi A, Jimenez-Hoy-uela J, Fraker D. PET evaluation of therapeutic limb perfusion in Merkel’s cell carcinoma. J Nucl Med 1998;39:2087–90

    PubMed  CAS  Google Scholar 

  17. Cabanas RM. An approach for the treatment of penile carcinoma. Cancer 1977;39:456–66

    Article  PubMed  CAS  Google Scholar 

  18. Giuliano AE, Kirgan DM, Guenther JM, Morton DL. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 1994;220:391–8

    Article  PubMed  CAS  Google Scholar 

  19. O’Brien CJ, Uren RF, Thompson JF, Howman-Giles RB, Petersen-Schaefer K, Shaw HM, et al. Prediction of potential metastatic sites in cutaneous head and neck melanoma using lymphoscintigraphy. Am J Surg 1995;170:461–6

    Article  PubMed  CAS  Google Scholar 

  20. Albertini JJ, Cruse CW, Rapaport D, Wells K, Ross M, DeConti R, et al. Intraoperative radio-lympho-scintigraphy improves sentinel lymph node identification for patients with melanoma. Ann Surg 1996;223:217–24

    Article  PubMed  CAS  Google Scholar 

  21. Alex JC, Krag DN. The gamma-probe-guided resection of radiolabeled primary lymph nodes. Surg Oncol Clin North Am 1996;5:33–41

    CAS  Google Scholar 

  22. Messina JL, Reintgen DS, Cruse CW, Rappaport DP, Berman C, Fenske NA, et al. Selective lymphadenectomy in patients with Merkel cell (cutaneous neuroendocrine) carcinoma. Ann Surg Oncol 1997;4:389–95

    Article  PubMed  CAS  Google Scholar 

  23. Pfeifer T, Weinberg H, Brady MS. Lymphatic mapping for Merkel cell carcinoma. J Am Acad Dermatol 1997;37:650–1

    Article  PubMed  CAS  Google Scholar 

  24. Ames SE, Krag DN, Brady MS. Radiolocalization of the sentinel lymph node in Merkel cell carcinoma: a clinical analysis of seven cases. J Surg Oncol 1998;67:251–4

    Article  PubMed  CAS  Google Scholar 

  25. Kelemen PR, Van Herle AJ, Giuliano AE. Sentinel lymphadenectomy in thyroid malignant neoplasms. Arch Surg 1998;133:288–92

    Article  PubMed  CAS  Google Scholar 

  26. Hill AD, Brady MS, Coit DG. Intraoperative lymphatic mapping and sentinel lymph node biopsy for Merkel cell carcinoma. Br J Surg 1999;86:518–21

    Article  PubMed  CAS  Google Scholar 

  27. Koops HS, Doting MH, de Vries J, Tiebosch AT, Plukker JT, Hoekstra HJ, et al. Sentinel node biopsy as a surgical staging method for solid cancers. Radiother Oncol 1999;51:1–7

    Article  PubMed  CAS  Google Scholar 

  28. Sian KU, Wagner JD, Sood R, Park HM, Havlik R, Coleman JJ. Lymphoscintigraphy with sentinel lymph node biopsy in cutaneous Merkel cell carcinoma. Ann Plast Surg 1999;42:679–82

    Article  PubMed  CAS  Google Scholar 

  29. De Cicco C, Sideri M, Bartolomei M, Grana C, Cremonesi M, Fiorenza M, et al. Sentinel node biopsy in early vulvar cancer. Br J Cancer 2000; 82:295–9

    Article  PubMed  Google Scholar 

  30. Zeitouni NC, Cheney RT, Delacure MD. Lymphoscintigraphy, sentinel lymph node biopsy, and Mohs micrographic surgery in the treatment of Merkel cell carcinoma. Dermatol Surg 2000;26:12–8

    Article  PubMed  CAS  Google Scholar 

  31. Munz DL, Altmeyer P, Sessler MJ, Hor G. Axillary lymph node groups—the center in lymphatic drainage from the truncal skin in man. Clinical significance for management of malignant melanoma. Lymphology 1982; 15:143–7

    PubMed  CAS  Google Scholar 

  32. Munz DL, Maza S, Ivancevic V, Geworski L. Classification of the lymphatic drainage status of a primary tumour: a proposal. Nuklearmedizin 2000; 39:88–91

    PubMed  CAS  Google Scholar 

  33. Maza S, Valencia R, Geworski L, Zander A, Drager E, Winter H, et al. Temporary shielding of hot spots in the drainage areas of cutaneous melanoma improves accuracy of lymphoscintigraphic sentinel lymph node diagnostics. Eur J Nucl Med Mol Imaging 2002;29:1399–402

    Article  PubMed  CAS  Google Scholar 

  34. Maza S, Valencia R, Geworski L, Sandrock D, Zander A, Audring H, et al. Influence of fast lymphatic drainage on metastatic spread in cutaneous malignant melanoma: a prospective feasibility study. Eur J Nucl Med Mol Imaging 2003; 30:538–44

    Article  PubMed  Google Scholar 

  35. Su LD, Lowe L, Bradford CR, Yahanda AI, Johnson TM, Sondak VK. Immunostaining for cytokeratin 20 improves detection of micrometastatic Merkel cell carcinoma in sentinel lymph nodes. J Am Acad Dermatol 2002;46:661–6

    Article  PubMed  Google Scholar 

  36. Stadelmann WK, Cobbins L, Lentsch EJ. Incidence of nonlocalization of sentinel lymph nodes using preoperative lymphoscintigraphy in 74 consecutive head and neck melanoma and Merkel cell carcinoma patients. Ann Plast Surg 2004;52:546–9

    Article  PubMed  Google Scholar 

  37. Schwarz M, Schwarz O, Audring H, Kuchler I, Winter H. Regional lymph node morphology in malignant melanomas and their prognostic value. Zentralbl Pathol 1994;139:457–64

    PubMed  CAS  Google Scholar 

  38. Meeuwissen JA, Bourne RG, Kearsley JH. The importance of postoperative radiation therapy in the treatment of Merkel cell carcinoma. Int J Radiat Oncol Biol Phys 1995;31:325–31

    Article  PubMed  CAS  Google Scholar 

  39. Fenig E, Brenner B, Katz A, Rakovsky E, Hana MB, Sulkes A. The role of radiation therapy and chemotherapy in the treatment of Merkel cell carcinoma. Cancer 1997;80:881–5

    Article  PubMed  CAS  Google Scholar 

  40. Mehrany K, Otley CC, Weenig RH, Philips PK, Roenigk RK, Nguyen TH. A meta-analysis of the prognostic significance of sentinel lymph node status in Merkel cell carcinoma. Dermatol Surg 2002;28:113–7

    Article  PubMed  Google Scholar 

  41. Blom A, Kolb F, Lumbroso J, Duvillard P, Mamelle G, Morzli K, et al. Significance of sentinel lymph node biopsy in Merkel cell carcinoma. Analysis of 11 cases. Ann Dermatol Venereol 2003;130:417–22

    PubMed  CAS  Google Scholar 

  42. Michl C, Starz H, Bachter D, Balda BR. Sentinel lymphonodectomy in nonmelanoma skin malignancies. Br J Dermatol 2003;149:763–9

    Article  PubMed  CAS  Google Scholar 

  43. O’Connor WJ, Brodland DG. Merkel cell carcinoma. Dermatol Surg 1996;22:262–7

    Article  PubMed  CAS  Google Scholar 

  44. Kurul S, Mudun A, Aksakal N, Aygen M. Lymphatic mapping for Merkel cell carcinoma. Plast Reconstr Surg 2000;105:680–3

    Article  PubMed  CAS  Google Scholar 

  45. Wasserberg N, Schachter J, Fenig E, Feinmesser M, Gutman H. Applicability of the sentinel node technique to Merkel cell carcinoma. Dermatol Surg 2000;26:138–41

    Article  PubMed  CAS  Google Scholar 

  46. Bilchik AJ, Giuliano A, Essner R, Bostick P, Kelemen P, Foshag LJ, et al. Universal application of intraoperative lymphatic mapping and sentinel lymphadenectomy in solid neoplasms. Cancer J Sci Am 1998;4:351–8

    PubMed  CAS  Google Scholar 

  47. Allen PJ, Busam K, Hill AD, Stojadinovic A, Coit DG. Immunohistochemical analysis of sentinel lymph nodes from patients with Merkel cell carcinoma. Cancer 2001;92:1650–5

    Article  PubMed  CAS  Google Scholar 

  48. Duker I, Starz H, Bachter D, Balda BR. Prognostic and therapeutic implications of sentinel lymphonodectomy and S-staging in Merkel cell carcinoma. Dermatology 2001;202:225–9

    Article  PubMed  CAS  Google Scholar 

  49. Rodrigues LK, Leong SP, Kashani-Sabet M, Wong JH. Early experience with sentinel lymph node mapping for Merkel cell carcinoma. J Am Acad Dermatol 2001;45:303–8

    Article  PubMed  CAS  Google Scholar 

  50. Pan D, Narayan D, Ariyan S. Merkel cell carcinoma: five case reports using sentinel lymph node biopsy and a review of 110 new cases. Plast Reconstr Surg 2002;110:1259–65

    Article  PubMed  Google Scholar 

  51. Morrison WH, Peters LJ, Silva EG, Wendt CD, Ang KK, Goepfert H. The essential role of radiation therapy in securing locoregional control of Merkel cell carcinoma. Int J Radiat Oncol Biol Phys 1990;19:583–91

    PubMed  CAS  Google Scholar 

  52. Allen PJ, Zhang ZF, Coit DG. Surgical management of Merkel cell carcinoma. Ann Surg 1999;229:97–105

    Article  PubMed  CAS  Google Scholar 

  53. Veness MJ, Morgan GJ, Gebski V. Adjuvant locoregional radiotherapy as best practice in patients with Merkel cell carcinoma of the head and neck. Head Neck 2005;27:208–16

    Article  PubMed  Google Scholar 

Download references

Acknowledgement

The authors would like to thank Deborah A. Landry, B.A., for editing the manuscript.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Sofiane Maza.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Maza, S., Trefzer, U., Hofmann, M. et al. Impact of sentinel lymph node biopsy in patients with Merkel cell carcinoma: results of a prospective study and review of the literature. Eur J Nucl Med Mol Imaging 33, 433–440 (2006). https://doi.org/10.1007/s00259-005-0014-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00259-005-0014-1

Keywords

Navigation